Evidence map›Paper›PMID 35843929›Full record

SynthesisBMC oral health2022

Impact of bisphosphonate drugs on dental implant healing and peri-implant hard and soft tissues: a systematic review.

Luca Fiorillo, Marco Cicciù, Tolga Fikret Tözüm, Cesare D'Amico, Giacomo Oteri, Gabriele Cervino

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in BMC oral health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Luca FiorilloDepartment of Biomedical and Dental Sciences, Morphological and Functional Images, University of Messina, Via Consolare Valeria, 1, 98100, Messina, Italy.ORCID 0000-0003-0335-4165
Marco CicciùDepartment of Biomedical and Dental Sciences, Morphological and Functional Images, University of Messina, Via Consolare Valeria, 1, 98100, Messina, Italy. mcicciu@unime.it.ORCID 0000-0003-2311-9728
Tolga Fikret TözümDepartment of Periodontics, University of Illinois at Chicago, College of Dentistry, Chicago, IL, USA.ORCID 0000-0002-7485-7272
Cesare D'AmicoDepartment of Biomedical and Dental Sciences, Morphological and Functional Images, University of Messina, Via Consolare Valeria, 1, 98100, Messina, Italy.ORCID 0000-0002-1378-2588
Giacomo OteriDepartment of Biomedical and Dental Sciences, Morphological and Functional Images, University of Messina, Via Consolare Valeria, 1, 98100, Messina, Italy.ORCID 0000-0002-0941-1645
Gabriele CervinoDepartment of Biomedical and Dental Sciences, Morphological and Functional Images, University of Messina, Via Consolare Valeria, 1, 98100, Messina, Italy.ORCID 0000-0003-4619-4691
University of Messina · ITUniversity of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveImplantology represents the gold standard for oral rehabilitation, unfortunately, often, despite there are no local contraindications to this type of rehabilitation, there are uncertainties regarding the general health of our patients. Many patients nowadays take bisphosphonate drugs, often without first seeking advice from an oral surgeon or a dentist. The purpose of this review is precisely to highlight any contraindications to this type of treatment reported in the literature, in patients who take or have taken bisphosphonate drugs.

methodsFor this study the scientific information sources were consulted using as search terms "("bisphosphonate AND "dental implant")", obtaining 312 results, these were subsequently skimmed according to the inclusion and exclusion criteria, and further evaluated their relevance to the study and the presence of requested outcomes.

resultsOnly 9 manuscripts (RCTs, Multicentric studies and Clinical Trials) were included in this review, as they respected the parameters of this review, they were analyzed and it was possible to draw important results from them. Surely from this study it is understood that the use of bisphosphonate drugs does not represent an absolute contraindication to implant therapy, it is evident how adequate pharmacological prophylaxis, and an adequate protocol reduce the risks regarding implant failures. Furthermore, the values of marginal bone loss over time seem, even if not statistically significant, to be better in implant rehabilitation with bisphosphonate drugs association. Only a few molecules like risedronate, or corticosteroids, or some conditions like smoking or diabetes have shown a high risk of surgical failure.

conclusionAlthough this study considered different studies for a total of 378 patients and at least 1687 different dental implants, showing better results in some cases for dental implant therapy in cases of bisphosphonate intake, further clinical, randomized and multicentric studies are needed, with longer follow-ups, to fully clarify this situation which often negatively affects the quality of life of our patients and places clinicians in the face of doubts.

Indexed as

Dental ImplantsDiphosphonatesDental Implantation, EndosseousDental Restoration FailureHumansQuality of LifeDental ImplantsDiphosphonatesBisphosphonateBone tissueDental implantOral surgeryOsseointegrationOsteoporosis

Identifiers

PMID35843929
PMCPMC9288700
OpenAlexW4285676845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.